Search clinical trials for: 68Ga-DOTATOC PET/CT

Total 1494 results

Assistance Publique Hopitaux De Marseille

Completed

[68 Ga]-DOTANOC PET/CT in GEP-NETs (GEP-NOC)

Gastroenteropancreatic Neuroendocrine Tumors

France
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
Turku University Hospital

Completed

Molecular and Whole-body MR Imaging in Lymphomas (MILY)

Lymphoma | Lymphoma, Non-Hodgkin | Hodgkin Disease

Finland
British Columbia Cancer Agency

Recruiting

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Prostatic Neoplasms | Prostate Cancer | Neuroendocrine Tumors | Neuroblastoma | Carcinoid Tumor | Paraganglioma

Canada
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
Central Hospital, Nancy, France

Completed

Pilot Study Evaluating Somatostatin Receptor's PET Imaging to Detect Inflammatory Phases of Myocarditis (DOTAMIR)

Myocarditis

France
Sue O'Dorisio

Completed

Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors (GA-68)

Neuroendocrine Tumors | Medulloblastoma | Neuroblastoma | Carcinoid Tumors

United States
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada
Sue O'Dorisio
University of Iowa

Completed

Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors

Neuroendocrine Tumors | Medulloblastoma | Neuroblastoma | Carcinoid Tumors

United States
Central Hospital, Nancy, France

Not yet recruiting

Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis (DOTENDO)

Infective Endocarditis
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

China
University Hospital, Bordeaux

Completed

PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation (GALTEP)

Neuroendocrine Tumors

France
University Hospital, Brest

Recruiting

Whole Body Dynamic 68Ga-DOTATOC PET/CT in Neuroendocrine Tumors (GAPET-NET)

Neuroendocrine Tumors

France
Mayo Clinic

Active, not recruiting

Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

Osteomalacia

United States
Jonsson Comprehensive Cancer Center

Completed

Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients

Neuroendocrine Carcinoma

United States
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

Primary Myelofibrosis

China
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Dotatate to Locate Coronary Plaques at High-risk of Myocardial Infarction (DOLPHIN)

Atheroscleroses, Coronary

Netherlands
Peking University Cancer Hospital & Institute

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor

China
The First Affiliated Hospital of Xiamen University

Recruiting

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

Ovarian Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

PD-L1 Targeting Molecular Imaging of Solid Tumors

Gastrointestinal Tumors

China
Jewish General Hospital

Completed

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Neuroendocrine Tumors

Canada
University of Alabama at Birmingham

Completed

PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

Metastatic Prostate Cancer

United States
Cancer Institute and Hospital, Chinese Academy...
Peking University; Peking University Cancer Hospital & Institute

Recruiting

68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer

Malignant Tumor | Positron Emission Tomography | Fibroblast Activation Protein Inhibitor

China
Peking Union Medical College Hospital

Active, not recruiting

Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)

Breast Cancer

China
Radboud University Medical Center

Terminated

Visualizing Beta Cells After Islet Transplantation (GLP1-transpl)

Type 1 Diabetes Mellitus

Netherlands, Sweden
Memorial Sloan Kettering Cancer Center

No longer available

68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial

Neuroendocrine Tumors

United States
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer

Pancreatic Cancer

China
Rigshospitalet, Denmark

Recruiting

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Non-small Cell Lung Cancer | Malignant Pleural Mesothelioma | Large Cell Neuroendocrine Carcinoma of the Lung

Denmark
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Terminated

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Italy
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Recruiting

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
Peter MacCallum Cancer Centre, Australia

Recruiting

Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions (SPECIFIC)

Invasive Fungal Infections

Australia
Lale Kostakoglu

Terminated

68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)

Neuroendocrine Tumors | Carcinoid Tumors

United States
First Affiliated Hospital of Fujian Medical University

Unknown

68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer

Metastasis | Tumor | Positron-Emission Tomography

China
Alberta Health services

Recruiting

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Neuroendocrine Tumors (NET)

Canada
The First Affiliated Hospital of Xiamen University

Recruiting

PET Imaging of LAG-3 Expression

Tumor, Solid

China
Radboud University Medical Center
Rijnstate Hospital

Recruiting

Visualizing Beta Cells After Bariatric Surgery (GLP1-bar)

Type 2 Diabetes Mellitus

Netherlands
Peking University Cancer Hospital & Institute

Recruiting

Research for the Molecular Imaging of the HER2 Targeting Tracer

HER2 Positive or Suspicious Positive Tumors

China
Peking Union Medical College Hospital

Active, not recruiting

FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy

Hepatocellular Carcinoma | Bile Duct Cancer

China
Jonsson Comprehensive Cancer Center

No longer available

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Neuroendocrine Tumors | Medullary Thyroid Cancer | Carcinoid Cancer | Cancers Expressing Somatostatin Receptors

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Von Hippel-Lindau Disease

Von Hippel-Lindau Disease

China
Peking Union Medical College Hospital

Unknown

68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis

Pulmonary Fibrosis, Unspecified

China
Guangdong Provincial People's Hospital
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Recruiting

A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors (68Ga-GPFAPI)

Cancer | Metastatic Cancer | Malignant Neoplasm | Tumors

China
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

Metastasis | Tumor | Positron-Emission Tomography

China
Xijing Hospital

Unknown

The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients

Colorectal Cancer

China
Rigshospitalet, Denmark
Curasight ApS

Completed

uPAR PET/CT for Preoperative Staging of Breast Cancer Patients

Breast Cancer

Denmark
Xiangya Hospital of Central South University

Recruiting

A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer

Prostate Cancer

China
University of Lausanne Hospitals
Swiss Heart Foundation

Recruiting

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

Inflammation | Carotid Artery Diseases | Atheromatous Plaques

Switzerland

Search clinical trials for: 68Ga-DOTATOC PET/CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations